TY - JOUR
T1 - Membrane Augmented Cell-Free Systems
T2 - A New Frontier in Biotechnology
AU - Kruyer, Nicholas S.
AU - Sugianto, Widianti
AU - Tickman, Benjamin I.
AU - Alba Burbano, Diego
AU - Noireaux, Vincent
AU - Carothers, James M.
AU - Peralta-Yahya, Pamela
N1 - Publisher Copyright:
© 2021 American Chemical Society. All rights reserved.
PY - 2021/4/16
Y1 - 2021/4/16
N2 - Membrane proteins are present in a wide array of cellular processes from primary and secondary metabolite synthesis to electron transport and single carbon metabolism. A key barrier to applying membrane proteins industrially is their difficult functional production. Beyond expression, folding, and membrane insertion, membrane protein activity is influenced by the physicochemical properties of the associated membrane, making it difficult to achieve optimal membrane protein performance outside the endogenous host. In this review, we highlight recent work on production of membrane proteins in membrane augmented cell-free systems (CFSs) and applications thereof. CFSs lack membranes and can thus be augmented with user-specified, tunable, mimetic membranes to generate customized environments for production of functional membrane proteins of interest. Membrane augmented CFSs would enable the synthesis of more complex plant secondary metabolites, the growth and division of synthetic cells for drug delivery and cell therapeutic applications, as well as enable green energy applications including methane capture and artificial photosynthesis.
AB - Membrane proteins are present in a wide array of cellular processes from primary and secondary metabolite synthesis to electron transport and single carbon metabolism. A key barrier to applying membrane proteins industrially is their difficult functional production. Beyond expression, folding, and membrane insertion, membrane protein activity is influenced by the physicochemical properties of the associated membrane, making it difficult to achieve optimal membrane protein performance outside the endogenous host. In this review, we highlight recent work on production of membrane proteins in membrane augmented cell-free systems (CFSs) and applications thereof. CFSs lack membranes and can thus be augmented with user-specified, tunable, mimetic membranes to generate customized environments for production of functional membrane proteins of interest. Membrane augmented CFSs would enable the synthesis of more complex plant secondary metabolites, the growth and division of synthetic cells for drug delivery and cell therapeutic applications, as well as enable green energy applications including methane capture and artificial photosynthesis.
KW - cell-free systems
KW - liposomes
KW - membrane proteins
KW - natural products
KW - synthetic cells
UR - http://www.scopus.com/inward/record.url?scp=85104900071&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104900071&partnerID=8YFLogxK
U2 - 10.1021/acssynbio.0c00625
DO - 10.1021/acssynbio.0c00625
M3 - Review article
C2 - 33749249
AN - SCOPUS:85104900071
SN - 2161-5063
VL - 10
SP - 670
EP - 681
JO - ACS Synthetic Biology
JF - ACS Synthetic Biology
IS - 4
ER -